Morgan Stanley Maintains Equal-Weight on Zimmer Biomet Holdings, Raises Price Target to $125
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Cecilia Furlong has maintained an Equal-Weight rating on Zimmer Biomet Holdings (NYSE:ZBH) and increased the price target from $120 to $125.
December 04, 2023 | 7:18 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has maintained an Equal-Weight rating on Zimmer Biomet Holdings and raised the price target to $125.
The increase in price target by a reputable analyst like Morgan Stanley suggests a positive outlook on the stock, which could lead to a short-term increase in investor confidence and potentially a rise in the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100